Company Quick10K Filing
CreditRiskMonitor.com
10-Q 2021-03-31 Filed 2021-05-14
10-K 2020-12-31 Filed 2021-03-25
10-Q 2020-09-30 Filed 2020-11-10
10-Q 2020-06-30 Filed 2020-08-13
10-Q 2020-03-31 Filed 2020-05-13
10-K 2019-12-31 Filed 2020-03-18
10-Q 2019-09-30 Filed 2019-11-14
10-Q 2019-06-30 Filed 2019-08-14
10-Q 2019-03-31 Filed 2019-05-14
10-K 2018-12-31 Filed 2019-03-22
10-Q 2018-09-30 Filed 2018-11-09
10-Q 2018-06-30 Filed 2018-08-10
10-Q 2018-03-31 Filed 2018-05-14
10-K 2017-12-31 Filed 2018-03-27
10-Q 2017-09-30 Filed 2017-11-13
10-Q 2017-06-30 Filed 2017-08-14
10-Q 2017-03-31 Filed 2017-05-15
10-K 2016-12-31 Filed 2017-03-24
10-Q 2016-09-30 Filed 2016-11-14
10-Q 2016-06-30 Filed 2016-08-10
10-Q 2016-03-31 Filed 2016-05-12
10-K 2015-12-31 Filed 2016-03-29
10-Q 2015-09-30 Filed 2015-11-13
10-Q 2015-06-30 Filed 2015-08-14
10-Q 2015-03-31 Filed 2015-05-15
10-K 2014-12-31 Filed 2015-03-27
10-Q 2014-09-30 Filed 2014-11-14
10-Q 2014-06-30 Filed 2014-08-14
10-Q 2014-03-31 Filed 2014-05-15
10-K 2013-12-31 Filed 2014-03-21
10-Q 2013-09-30 Filed 2013-11-14
10-Q 2013-06-30 Filed 2013-08-14
10-Q 2013-03-31 Filed 2013-05-15
10-K 2012-12-31 Filed 2013-03-25
10-Q 2012-09-30 Filed 2012-11-14
10-Q 2012-06-30 Filed 2012-08-14
10-Q 2012-03-31 Filed 2012-05-15
10-K 2011-12-31 Filed 2012-03-28
10-Q 2011-09-30 Filed 2011-11-14
10-Q 2011-06-30 Filed 2011-08-12
10-Q 2011-03-31 Filed 2011-05-12
10-K 2010-12-31 Filed 2011-03-18
10-Q 2010-09-30 Filed 2010-11-12
10-Q 2010-06-30 Filed 2010-08-10
10-Q 2010-03-31 Filed 2010-05-14
10-K 2009-12-31 Filed 2010-03-29
8-K 2020-12-29 Officers
8-K 2020-10-29
8-K 2020-07-28
8-K 2020-07-24
8-K 2020-05-12
8-K 2020-05-06
8-K 2020-03-16
8-K 2020-03-09
8-K 2019-11-12
8-K 2019-10-24
8-K 2019-08-06
8-K 2019-07-24
8-K 2019-05-09
8-K 2019-03-18
8-K 2018-11-14
8-K 2018-11-08
8-K 2018-08-02
8-K 2018-07-31
8-K 2018-05-09
8-K 2018-03-22

CreditRiskMonitor.com Financials

CRMZ Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
024 Pharma (EEIG)
11 Good Energy (ELVN)
Supernova Partners Acquisition Co III, Ltd. (STRE-WT)
1347 Capital Corp (TFSC)
Ameri Metro, Inc. (formerly Yellowwood) (ARMT)
Gores Technology Partners, Inc. (GTPAW)
Bioquest Corp (BQST)
BriaCell Therapeutics Corp. (BCTXW)
Ameren Illinois Co (AILNP)
DD3 Acquisition Corp. II (DDMXW)
8i Acquisition 2 Corp. (LAX)
Acumen Pharmaceuticals, Inc. (ABOS)
Aerovate Therapeutics, Inc. (AVTE)
Frontier Investment Corp (FICV)
Gobi Acquisition Corp. (GOBI)
1PM Industries (OPMZ)
1st Century Bancshares (FCTY)
HEALTH REVENUE ASSURANCE HOLDINGS, INC. (HRAA)
Ocean Biomedical, Inc. (OCEA)
ALABAMA POWER CO (APRCP)

Balance Sheet ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash6,4156,1636,5316,9177,6747,6896,4226,8387,2987,2316,6496,5767,3917,5607,5297,7657,9168,2278,7188,6209,2879,5619,2228,8439,1999,2858,7358,7208,7648,6068,0678,3908,4038,568
Accounts Receivable1,4891,2251,5511,8621,0121,2441,7761,5481,0771,0621,7081,5711,3051,7652,0791,4411,6171,3781,9272,0321,5551,4902,0911,9221,7931,5132,1401,9751,8051,5702,4551,9541,9291,845
Inventory
PP&E3323213072952962821,1992352853851,5254153673431,5803024124251,8564704384031,9074383993852,0423993615532,092533555515
Assets11,74211,79112,57113,22312,98613,24112,71013,22013,04112,67212,73712,42813,22813,78313,80413,45514,10914,04014,02414,49114,47414,41614,20913,56714,03713,72613,82113,60313,79413,26313,61716,04316,17515,880
Accounts Payable5666617375864465118778659761481374383112786113316397678313659146971459522612726
Long-Term Debt
Liabilities7,2027,3837,7818,3257,9437,8788,7819,2198,9598,3468,7018,6459,1969,5939,7279,2449,6979,3299,56710,08610,05110,02510,2439,81010,32910,00110,23810,25110,5039,96110,65913,20813,33712,826
Stockholders' Equity4,5404,4084,7904,8975,0435,3633,9294,0004,0824,3264,0363,7834,0324,1904,0764,2124,4124,7114,4574,4054,4234,3913,9663,7573,7083,7253,5823,3523,2913,3012,9582,8362,8383,054
Income Statement ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue2,5392,5802,5952,6452,7402,8222,8552,8662,9343,0143,0242,9692,9983,0853,1513,0703,1073,1533,1563,1173,1763,2383,2843,2363,3413,3853,4223,3723,4783,4813,4963,5683,673
Cost of Revenue7357161,1149279369149541,0371,1361,0751,1901,3011,0221,1661,2321,2301,1701,1341,1311,2561,1731,2541,2611,3961,4721,3331,3681,4841,4141,417
Gross Profit1,8041,8641,4801,7191,8041,9081,9011,8291,7981,9391,8331,6681,9761,9191,9191,8401,9372,0192,0251,8612,0031,9842,0221,8401,8692,0532,0541,8882,0642,065
R&D
SG&A1,4961,5729671,5971,5661,4281,6161,7351,6531,5781,6461,7461,8251,6141,5511,7311,6391,6361,6791,9702,0031,8081,7142,1132,0732,0141,8442,1882,1502,0602,1672,1481,962
Tax917214732105182154212912762135911814925103130168-51-1246167-74-1830-180-71-113-14-274
Net Income2102293414810927491324419274-13921712616737135194127-90-218083-244-84-19359-255-87-11-136-12204
Cash Flow ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating68838438979752312426546-163-107-25824213185289318-1632868328935-32111687-6488436385178
Cash Investing-545-22-26-40-37-14-10-8579-77-49-9-44-18-170-801,067-125-17-15162-58-29-101-9-3-242-40-72-13
Cash Financing-39662300-1,5650017-398100683372-413000-536